IL Science Co. Ltd (307180) — Capital Reinvestment Ratio

Latest as of September 2025: 1.32x

IL Science Co. Ltd (307180) has a Capital Reinvestment Ratio of 1.32x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.94 Billion) in capital expenditures (₩2.56 Billion). Check IL Science Co. Ltd (307180) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.32x

Capex / Operating Cash Flow

Operating Cash Flow

₩1.94 Billion

KRW

Capital Expenditures

₩2.56 Billion

KRW

Data as of

Sep 2025

Most recent filing

IL Science Co. Ltd Capital Reinvestment Ratio (2022–2022)

This chart tracks IL Science Co. Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see 307180 operating cash flow.

Annual Capital Reinvestment Ratio for IL Science Co. Ltd (2022–2022)

Year-by-year Capital Reinvestment Ratio for IL Science Co. Ltd from 2022 to 2022. See 307180 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2022	4.04x	₩1.56 Billion	₩6.29 Billion	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow